Abstract:Previous studies revealed that phenylhistamines and histaprodifens possess higher potency and affinity at guinea pig histamine H(1)-receptor (gpH(1)R) than at human histamine H(1)-receptor (hH(1)R). However, we recently identified an imidazolylpropylguanidine [N(1)-(3-cyclohexylbutanoyl)-N(2)-[3-(1H-imidazol-4-yl)-propyl]guanidine (UR-AK57)] with higher potency and efficacy at hH(1)R compared with gpH(1)R. The aim of this study was to reveal the molecular basis for the species differences of synthetic ligands. We studied 11 novel phenylhistamines and phenoprodifens. H(1)R species isoforms were expressed in Sf9 insect cells, and [(3)H]mepyramine competition binding and GTPase assays were performed. We identified bulky phenylhistamines with higher potency and affinity at hH(1)R compared with gpH(1)R. Molecular dynamics simulations of ligand-H(1)R interactions revealed four potential binding modes for phenylhistamines possessing an additional histamine moiety; the terminal histamine moiety showed a high flexibility in the binding pocket. There are striking similarities in ligand properties in bulky phenylhistamines and UR-AK57. Comparison of bulky phenylhistamine binding mode with binding mode of UR-AK57 suggests that only one of these four binding modes should be established. The higher potency is explained by more effective van der Waals interaction of the compounds with Asn(2.61) (hH(1)R) relative to Ser(2.61) (gpH(1)R). In addition, two stable binding modes for phenoprodifens with different orientations in the binding-pocket were identified. Depending on phenoprodifen orientation, the highly conserved Trp(6.48), part of the toggle switch involved in receptor activation, was found in an inactive or active conformation, respectively. We identified the first phenylhistamines with higher potency at hH(1)R than at gpH(1)R and obtained insight into the binding mode of bulky phenylhistamines and imidazolylpropylguanidines.

Light-Switchable Antagonists for the Histamine H1 Receptor at the Isolated Guinea Pig Ileum

Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor

Structure-Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands†

In Silico Analysis, Synthesis, and Biological Evaluation of Triazole Derivatives as H1 Receptor Antagonist

Synthesis and Pharmacological Characterization of New Photocaged Agonists for Histamine H3 and H4 Receptors

Non-Imidazole Histamine H3 Ligands. Part VII. Synthesis, In Vitro and In Vivo Characterization of 5-Substituted-2-thiazol-4-n-propylpiperazines

Synthesis and Antihistamine Evaluations of Novel Loratadine Analogues

Novel Heterocyclic-Substituted Benzofuran Histamine H-3 Receptor Antagonists: in Vitro Properties, Drug-Likeness, and Behavioral Activity

In Silico Binding Characteristics Between Human Histamine H-1 Receptor and Antagonists

Structural basis of ligand recognition and design of antihistamines targeting histamine H4 receptor

Photoswitchable TCB-2 for Control of the 5-HT2A Receptor and Analysis of Biased Agonism

Pharmacological characterization of seven human histamine H3 receptor isoforms

Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists.

A high-affinity, cis-on photoswitchable beta blocker to optically control β2-adrenergic receptors in vitro and in vivo

Azobenzene-Isoxazoline As Photopharmacological Ligand for Optical Control of Insect GABA Receptor and Behavior.

Comparison of the pharmacological properties of human and rat histamine H(3)-receptors

Design, synthesis and pharmacological characterization of the first photoswitchable small-molecule agonist for the Atypical Chemokine Receptor 3

Cross-Desensitization and Cointernalization of H1 and H2 Histamine Receptors Reveal New Insights into Histamine Signal Integration

Design, Synthesis and Biological Activity of a Novel Ethylenediamine Derivatives As H1 Receptor Antagonists.

Synthesis And Characterization Of 5-Hydroxy-2-(2-Phenylethyl)Chromone (5-Hpec) And Its Analogues As Non-Nitrogenous 5-Ht2b Ligands

Azobenzene-diamides as Photopharmacological Ligands for Insect Ryanodine Receptor